A VCP variant was linked to an unusual pattern of tau buildup in the nervous system
Provides detailed evidence about VCP variants, astrocytic tau aggregation and multisystem proteinopathy.
Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.
Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.
Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.
Sponsors
What we are learning about mechanism, genetics, biomarkers and epidemiology.
Showing 200 of 943 stories
Provides detailed evidence about VCP variants, astrocytic tau aggregation and multisystem proteinopathy.
· October 2026
Relevant to researchers studying astrocyte dysfunction, evolution, and cell-specific therapeutic targets in ALS.
· September 2026
Mainly of interest to researchers studying ALS trajectories, disparities and longitudinal modelling.
· 2 days ago
Mainly of interest to researchers studying apoptosis and ALS motor-neuron models
· 2 days ago
Introduces programmable nanopores for single-molecule profiling of disease-associated proteins, including ALS-linked SOD1 peptides.
· 2 days ago
Mainly of interest to researchers studying genotype–phenotype relationships and cognitive outcomes
· 2 days ago
Provides matched case-control evidence and exposure methods for studying urbanization and greenness.
· 2 days ago
Relevant to researchers studying repeat expansions, gene dosage and ALS mechanisms
· 3 days ago
Mainly of interest to researchers studying ALS prognosis and epidemiology
· 3 days ago
Directly informs HDAC inhibition, SOD1 aggregation and ALS model research
· 3 days ago
Directly informs targeted autophagy and extracellular-vesicle strategies for TDP-43 pathology
· 4 days ago
Mainly of interest to researchers studying nucleolar stress, C9orf72-linked ALS/FTD and neurodegeneration.
· 5 days ago
Mainly of interest to researchers studying SIGMAR1 genetics and motor-neuropathy classification
· 5 days ago
Provides mechanistic and outcome data on NLRP3 inflammasome modulation in an SOD1 ALS mouse model.
· 5 days ago
Detailed synthesis of neuroimmune mechanisms, biomarkers and trial-design priorities.
· 6 days ago
Relevant to researchers studying genotype-linked cognitive and affective theory-of-mind impairment
· 6 days ago
Directly advances research on ATXN2 splicing, ASOs and TDP-43 pathology
· 6 days ago
Directly relevant to researchers studying TDP-43 pathology, staging and mechanism-based biomarkers.
· 6 days ago
Summarises engineering, delivery, safety and translational questions in living microbial therapeutics.
· 6 days ago
Directly informs glial sphingolipid biology, lipid-droplet readouts and age-related motor dysfunction.
· 6 days ago
Mainly of interest to researchers examining TDP-43 disease mechanisms and diagnostic concepts.
· 6 days ago
Provides computational targets and pathways for investigating non-nutritive sweeteners in ALS and neuroinflammation.
· 6 days ago
Directly relevant to researchers studying environmental epidemiology and ALS risk.
· 7 days ago
Mainly of interest to researchers studying FUS variants and phenotypic heterogeneity.
· 7 days ago
Provides validated C9orf72 patient-derived iPSC lines for disease-mechanism studies.
· 8 days ago
Relevant to clinicians evaluating possible ALS mimics and differential diagnoses.
· 9 days ago
Provides replicated donor-level lncRNA findings and methodological insights for ALS neurobiology research
· 9 days ago
Mainly of interest to researchers studying neurovascular coupling, cognition, and fNIRS biomarkers in ALS.
· 9 days ago
Mainly of interest to researchers studying motor-unit vulnerability and disease mechanisms
· 9 days ago
Relevant to researchers studying TDP-43 pathology, transcriptional states and therapeutic targets
· 9 days ago
Relevant to researchers studying ALS epidemiology, prediction and risk factors
· 10 days ago
Provides a new Wasserstein-distance method and classification data for PET-based network research
· 10 days ago
Important for researchers studying TDP-43, satellite-cell maintenance and skeletal-muscle regeneration.
· 10 days ago
Important for researchers studying TAF15, oxidative stress, gliosis and potential antioxidant interventions.
· 10 days ago
Mainly of interest to researchers studying neurodegenerative biomarkers, CCM metrics and protocol standardisation.
· 10 days ago
Mainly of interest to researchers studying Complex V, bioenergetics and neurodegeneration.
· 10 days ago
Relevant to clinicians applying and interpreting ALS diagnostic criteria
· 11 days ago
Mainly of interest to researchers studying environmental determinants and ALS survival.
· 11 days ago
Synthesises lncRNA ceRNA mechanisms, evidence gaps and research directions in motor neuron disease
· 11 days ago
Relevant to researchers studying mitochondrial dysfunction, targeted delivery and translational barriers in ALS.
· 11 days ago
Relevant to researchers studying neuroinflammation, immune-cell states and stage-dependent therapeutic targets.
· 12 days ago
Mainly of interest to researchers following PCSK9 biology, genetics and therapeutic mechanisms.
· 12 days ago
Relevant to researchers tracking stem-cell strategies, clinical advances and open questions in neurodegeneration
· 12 days ago
Introduces a large-sample functional TDP-43 serum assay with genotype and longitudinal analyses
· 13 days ago
Relevant to researchers studying regulated cell death, neuroinflammation and translational therapeutic targets in ALS.
· 13 days ago
Relevant to clinicians assessing nutrition within healthcare and referral contexts
· 15 days ago
Mainly of interest to researchers studying environmental factors and disease onset
· 16 days ago
Provides machine-learning, transcriptomic, pathway, and drug-repurposing hypotheses for further validation.
· 16 days ago
Provides a systematic review and computational analysis of circRNAs, RNA-binding proteins, and ALS mechanisms.
· 16 days ago
Relevant to researchers studying UNC13A cryptic splicing, TDP-43 pathology and neurodegeneration.
· 16 days ago
Important for researchers studying cortical hyperexcitability and multisystem MND mechanisms.
· 16 days ago
Relevant to researchers studying environmental neurotoxicity, oxidative stress and disease mechanisms.
· 16 days ago
Mainly of interest to researchers studying shared sleep-wake mechanisms and neuronal hyperexcitability in neurodegeneration
· 16 days ago
Mainly of interest to researchers following AI-based voice biomarkers and diagnostic methods.
· 17 days ago
Important for researchers studying selective TTBK1 inhibition, TDP-43 pathology and translational models.
· 17 days ago
Important for multinational ALS outcomes research and health-economic comparisons
· 17 days ago
Mainly of interest to researchers studying MND epidemiology and demographic variation.
· 17 days ago
Important for researchers studying ALS epidemiology, physical activity and genetic risk interactions.
· 17 days ago
Relevant to researchers studying mitophagy mechanisms and therapeutic opportunities in neurodegeneration.
· 17 days ago
Relevant to researchers studying scientific communication, reporting bias and AI use of abstracts.
· 17 days ago
Relevant to researchers tracking corrections to motoneuron-loss research involving BIM.
· 17 days ago
Useful historical context for researchers studying ALS classification and multisystem disease features.
· 17 days ago
Mainly of interest to researchers studying ALS biomarkers and therapeutic response
· 18 days ago
Mainly of interest to researchers studying environmental exposures and ALS epidemiology.
· 18 days ago
Directly informs viscosity sensing, TDP-43 aggregation and controlled drug release methods
· 18 days ago
Relevant to researchers studying ALS gene discovery, pedigrees and rare-variant methods.
· 18 days ago
Defines a redox-dependent ATM-CHK2-SOD1 pathway and identifies ADH5/GSNOR as a potential target.
· 18 days ago
Provides a guinea-pig pregnancy model and maternal-fetal transcriptomic data for Nrf2 and DMF research.
· 18 days ago
Mainly of interest to researchers studying apathy phenotypes and neurodegenerative disease assessment.
· 18 days ago
Mainly of interest to researchers studying clinical phenotypes and personalised brain-computer interface design
· 18 days ago
Directly relevant to researchers studying cGAS-STING mechanisms and therapeutic development across neurodegenerative diseases.
· 18 days ago
Mainly of interest to researchers studying SOD1 activity, mutation effects and tofersen mechanisms.
· 19 days ago
Mainly of interest to researchers studying age-dependent ALS genetics and trial design.
· 19 days ago
Mainly of interest to researchers studying voice biomarkers, cognition and neurodegenerative disease.
· 19 days ago
Provides a mechanistic framework linking metabolic, mitochondrial and inflammatory pathways across neurodegenerative diseases.
· 19 days ago
Relevant to researchers studying neuron-driven neuroinflammation and therapeutic targets in ALS.
· 19 days ago
Relevant to researchers studying synaptic pathology, SV2A PET methods, and ALS biomarker development.
· 19 days ago
Mainly of interest to researchers studying myokines, microbiota and neuroinflammatory mechanisms in neurodegeneration.
· 19 days ago
Relevant to researchers studying epigenetic aging, LINE-1 activity and ALS mechanisms.
· 19 days ago
Relevant to researchers tracking oxidative stress, mitochondrial dysfunction and antioxidant-delivery strategies in ALS.
· 19 days ago
Important for researchers studying environmental epidemiology and ALS causation.
· 20 days ago
Relevant to clinicians using neck weakness as a marker for respiratory monitoring and prognosis.
· 20 days ago
Directly relevant to rare-variant methods, biobank controls, and candidate ALS predisposition genes
· 20 days ago
Provides imaging evidence linking glymphatic dysfunction with motor neuron disease phenotypes and white-matter damage
· 20 days ago
Mainly of interest to researchers studying excitotoxicity, oxidative stress and metabolic biomarkers.
· 20 days ago
Relevant to researchers assessing interpretation and debate around a respiratory biomarker study
· 20 days ago
Provides a knock-in model linking HSPB8, autophagy and TDP-43 pathology and tests trehalose preclinically.
· 21 days ago
Directly relevant to researchers studying SOD1 models and genome-editing therapy evaluation.
· 22 days ago
Relevant to researchers studying selective muscle involvement and diagnostic biomarkers in ALS.
· 22 days ago
Provides a framework and research directions for integrating intrinsic growth pathways with engineered environments
· 22 days ago
Mainly of interest to researchers studying ALS causation and disease-associated injuries.
· 23 days ago
Relevant to clinicians evaluating ultrasound alongside EMG in suspected MND
+3 · 23 days ago
Important for researchers studying nucleolar integrity, arginine-rich dipeptide repeats and C9orf72-linked neurodegeneration.
· 23 days ago
Relevant to clinicians evaluating potentially reversible mimics of motor neuron disease.
· 23 days ago
Mainly of interest to researchers studying IL-6 signalling, neuroinflammation and therapeutic targets.
· 23 days ago
Provides an AI-based 3D segmentation method and regional data on TDP-43–tau inclusion maturation.
· 23 days ago
Mainly of interest to researchers studying FTD classification, neuroimaging and clinical phenotypes.
· 23 days ago
Mainly of interest to researchers assessing anti-glycolipid antibodies and ALS respiratory outcomes.
· 23 days ago
Relevant to clinicians evaluating diagnostic accuracy and potential blood-test use
· 24 days ago
Directly informs TDP-43 mechanisms, neuroinflammation, metabolism and biomarker target engagement
· 24 days ago
Directly informs extracellular-vesicle therapy, motor-neuron protection and p53-pathway research.
· 24 days ago
Directly informs microglial phagocytosis, autophagy, lysosomal pathways, and C9orf72 versus sporadic disease models.
· 24 days ago
Directly informs TDP-43 immunohistochemistry, pathology subtyping and translational biomarker development
· 24 days ago
Synthesizes how SQSTM1 post-translational modifications regulate autophagy and neurodegeneration.
· 24 days ago
Relevant to researchers studying cortical excitability and imaging biomarkers in ALS
· 24 days ago
Important to researchers studying gene therapy and survival outcomes in ALS models.
· 25 days ago
Mainly of interest to researchers studying MND genetics, testing patterns, and population variation.
· 25 days ago
Provides high-resolution structural and biophysical insight into nanobody binding mechanisms for EphA4.
· 25 days ago
Directly relevant to researchers developing covariate-adjusted statistical methods for ALS randomized trials.
· 25 days ago
Important for researchers studying glial toxicity, DPRs, ERV activation and C9orf72 disease models
· 25 days ago
Mainly of interest to researchers studying ALS microbiome composition, nutrition and potential microbiome-targeted interventions.
· 25 days ago
Offers experimental evidence linking spinal GABA synthesis inhibition to motor-neuron degeneration.
· 25 days ago
Relevant to researchers studying C9orf72, proteostasis and neurodegenerative disease mechanisms.
· 25 days ago
Mainly of interest to researchers studying cellular mechanisms of ALS cognitive phenotypes
· 26 days ago
Mainly of interest to researchers studying SOD1 genotype–phenotype relationships and diagnostic latency.
· 26 days ago
Provides mechanistic evidence linking RNA-exosome surveillance and EXOSC3 to RAN translation and DPR production.
· 26 days ago
Directly advances mechanistic understanding of TDP-43 autoregulation and insoluble accumulation
· 26 days ago
Mainly of interest to researchers studying quantitative bulbar biomarkers and ultrasound methods.
· 26 days ago
Directly reviews stress granules, TDP-43 aggregation, USP10 and therapeutic research directions.
· 26 days ago
Relevant to clinicians distinguishing myofibrillar myopathy from ALS.
· 26 days ago
Provides transgenerational oxidative-stress and antioxidant-gene findings for researchers studying toxicology and disease mechanisms.
· 26 days ago
Mainly of interest to researchers studying septin autoimmunity, diagnostic biomarkers and disease mechanisms.
· 27 days ago
Mainly of interest to researchers studying environmental exposures, neurotoxicity and ALS aetiology.
· 27 days ago
Directly informs proteomic signatures, genetic subgroup biology and diagnostic panel development.
· 27 days ago
Relevant to researchers studying cortical hyperexcitability and ALS pathophysiology.
· 27 days ago
Provides an umbrella synthesis of QSM methods, iron patterns, and evidence limitations across neurodegenerative diseases.
· 27 days ago
Provides a focused review of intron retention, RNA biology, RBPs and therapeutic research directions in ALS.
· 27 days ago
Directly informs sex-stratified genetic and immune-mechanism research
· 27 days ago
Relevant to researchers studying stem cells, iPSC models, regenerative medicine and ALS drug discovery.
· 27 days ago
Relevant to researchers studying astrocytes, tau aggregation and selective vulnerability across neurodegenerative conditions.
· 27 days ago
Provides a lineage-calibrated framework for interpreting monocyte states, disease models, and therapeutic targets.
· 28 days ago
Mainly of interest to researchers studying MND epidemiology, under-recognition and registries
· August 2026
Provides muscle-specific lipid mediator data, human transcriptomic comparison and a negative therapeutic test
· August 2026
Provides a systematic synthesis of animal-model genetic therapy efficacy and bias.
· August 2026
Mainly of interest to researchers developing ALS neuropsychological phenotypes
· August 2026
Directly informs CSF biomarker, genotype, progression, and FTLD mechanism research
· 29 days ago
Provides longitudinal biomarker timing and a framework for staging FTLD-associated syndromes.
· August 2026
Mainly of interest to researchers studying extramotor involvement and PLS cognitive profiles
· August 2026
Mainly of interest to researchers studying TDP-43 pathology, cryptic exons, biomarkers and trial methodology.
· 29 days ago
Directly informs research on PML nuclear bodies and TDP-43 inclusion formation
· 29 days ago
Provides a cross-disease synthesis of microglial mitochondrial mechanisms and research targets.
· 29 days ago
Relevant to researchers studying TDP-43, protein pathology, autopsy methods and environmental exposure.
· 29 days ago
Mainly of interest to researchers studying proteomic, viral, glial and neuroinflammatory mechanisms linked to ALS.
· August 2026
Relevant to researchers studying TDP-43 fragment biology and AI-based neuropathological quantification.
· August 2026
Provides cohort evidence on locus coeruleus TDP-43 pathology, aging and clinical correlates.
· 29 days ago
Mainly of interest to researchers studying TDP-43 pathology, aging and hormone effects.
· August 2026
Reviews ATXN1 gain- and loss-of-function evidence and its association with ALS and other neurological diseases
· 29 days ago
Directly concerns how ALS-associated mutations disrupt cellular protein machinery
· 1 month ago
Relevant to clinicians updating ALS genetic-testing practice and counselling
· 1 month ago
Mainly of interest to researchers studying MND genetics and regional variation
· 1 month ago
Directly informs motoneuron excitability methods and hypotheses about muscle-specific recruitment in ALS.
· 1 month ago
Relevant to researchers studying oligodendrocyte dysfunction and myelination pathways in ALS
· 1 month ago
Mainly of interest to researchers developing and validating ALS digital biomarkers
· 1 month ago
Mainly of interest to researchers studying behavioral phenotypes, reserve, and risk stratification.
· 1 month ago
Provides free-water-corrected diffusion MRI findings, clinical correlations and a preliminary diagnostic model.
· 1 month ago
Provides negative case-control evidence about chromosomal-instability markers in ALS.
· 1 month ago
Relevant to clinicians evaluating diagnostic delays and subtype-specific assessment.
· 1 month ago
Relevant to assessing suicidality and psychosocial risk factors in early ALS care.
· 1 month ago
Mainly of interest to researchers studying ALS epidemiology and occupational exposures.
· 1 month ago
Summarises tau, RNA, and stress-granule mechanisms that open questions for neurodegeneration research.
· 1 month ago
Provides a broad framework linking DNMT1, environmental exposures, sex hormones, and ALS mechanisms.
· 1 month ago
Mainly of interest to researchers studying ALS epidemiology and military exposures
· 1 month ago
Mainly of interest to researchers studying ALS genetics and diagnostic yield
· 1 month ago
Offers spatial multi-omics data on distinct cortical and spinal molecular signatures and glial interactions.
· 1 month ago
Provides mechanistic and longitudinal biomarker data linking cortical excitability with MRS profiles
· 1 month ago
Provides mechanistic and structural evidence on phosphorylation-controlled TDP-43 assembly
· 1 month ago
Mainly of interest to researchers studying cognitive reserve, disease progression and ALS cognitive phenotypes.
· 1 month ago
Relevant to researchers studying shared ALS–depression mechanisms, transcriptomics, autophagy, and NAD+-linked pathways.
· 1 month ago
Directly informs longitudinal proteomics, phenoconversion prediction and prevention-trial design.
· 1 month ago
Important for researchers studying synaptic dysfunction, cryptic transcripts, and C9ORF72 mechanisms.
· 1 month ago
Important for researchers studying stress signaling, ENL/AF9, and disease-context-dependent ALS mechanisms.
· 1 month ago
Provides molecular and structural evidence on how methionine oxidation alters TDP-43 phase separation.
· 1 month ago
Directly informs researchers studying AAV biodistribution, caveolin-1 biology and ALS motor-neuron models.
· 1 month ago
Mainly of interest to researchers studying auditory biomarkers and neurodegenerative disease mechanisms.
· 1 month ago
Mainly of interest to researchers studying multimodal biomarkers, neuropathology prediction, and explainable AI.
· 1 month ago
Mainly of interest to researchers studying R-loops, TDP-43/FUS, SETX and neurodegeneration
· 1 month ago
Provides population-based data on ARTAG prevalence, anatomical patterns and associations with TDP-43 and vascular pathology.
· 1 month ago
Mainly of interest to researchers studying proteostasis, chaperones and ALS mechanisms.
· 1 month ago
Relevant to researchers studying proteostasis, mitochondrial function, neuroimmune regulation and disease thresholds.
· 1 month ago
Relevant to researchers studying neurotoxicity, stem-cell models and nervous-system biomarkers
· 1 month ago
Mainly of interest to researchers studying ALS progression, survival and cardiac biomarkers.
· 1 month ago
Relevant to researchers studying causal plasma proteins, proteomics and neurodegenerative disease mechanisms.
· 1 month ago
Important for researchers studying SOD1 pathology, sensory pathways and disease-modifying factors in a canine model.
· 1 month ago
Mainly of interest to researchers studying FUS-ALS phenotypes and genotype-phenotype links.
· 1 month ago
Directly relevant to researchers studying ADAR dysregulation, RNA editing mechanisms, and therapeutic delivery
· 1 month ago
Relevant to researchers studying microbiota-gut-brain mechanisms, disease signatures and translational research gaps.
· 1 month ago
Provides a CRISPR Drosophila model linking glial Fos/Kayak regulation to age-dependent neuroinflammation and motor decline.
· 1 month ago
Relevant to researchers studying retinal neurodegeneration and biomarker validation in ALS.
· 1 month ago
Directly informs complement mechanisms, therapeutic targeting and ALS translational research
· 1 month ago
Mainly of interest to researchers studying complementary ALS biomarkers and disease modelling.
· 1 month ago
Provides integrated lipidomic and proteomic evidence about shared lysosomal and lipid-homeostasis pathways across FTLD and Alzheimer’s disease.
· 1 month ago
Mainly of interest to researchers studying ATXN2 haplotypes, repeat interruptions and ALS genetics.
· 1 month ago
Relevant to researchers studying sex-associated biomarkers, ultrasound measures, and ALS progression.
· 1 month ago
Important for researchers studying RAN translation and neuron-specific translational regulation
· 1 month ago
Relevant to clinicians performing bulbar electromyography and evaluating diagnostic options.
· 1 month ago
Relevant to researchers studying NfL validation and disease- or intervention-specific biomarker interpretation
· 1 month ago
Mainly of interest to researchers studying MND epidemiology, burden trends and risk factors.
· 1 month ago
Directly informs ALS network mechanisms, human cellular modelling, electrophysiology, and compensation hypotheses.
· 1 month ago
Offers a FUS zebrafish screening platform and mechanistic evidence for tribenzylamine.
· 1 month ago
Important for researchers evaluating extracellular-vesicle biomarker performance, heterogeneity, and replication needs.
· 2 months ago
Summarised by Compass using AI from the source material. These are not medical advice. Always read the original source.
Sponsors